Glycohale FB Inhaler 120 MDI

Glycohale FB Inhaler 120 MDI is used as a maintenance treatment in patients with chronic obstructive pulmonary disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).

Glycohale FB Inhaler 120 MDI contains Formoterol fumarate dihydrate (bronchodilator), glycopyrrolate (anticholinergic), and budesonide (corticosteroid). Formoterol fumarate dihydrate works by relaxing muscles and widening the lungs' airways. Glycopyrrolate reduces secretions in the airways. Budesonide is a corticosteroid that acts on nasal lining cells and prevents the release of certain chemicals that cause inflammation.

Glycohale FB Inhaler 120 MDI may cause certain side effects such as oral thrush, cough, difficulty breathing, chills, back pain, muscle spasms, low blood pressure, nausea, and vomiting. Inform your doctor if these side effects persist or worsen. This medicine is for inhalation only. Before using, check the labelled instructions carefully.

Inform your doctor if you are allergic to Glycohale FB Inhaler 120 MDI. Before taking $ name, let your doctor know if you have any history of liver/kidney disease, glaucoma, asthma, heart disease, seizures, weak immune system, osteoporosis, diabetes, or medication history of anticholinergics, atropine, other LABA drugs, antifungal, or anti-HIV medicines. If you are pregnant or breastfeeding, please inform your doctor before using Glycohale FB Inhaler 120 MDI. This medicine is contraindicated for use in asthma patients.

Glycohale FB Inhaler 120 MDI is a combination medicine containing Formoterol fumarate dihydrate, Glycopyrrolate, and Budesonide. Formoterol fumarate dihydrate works by relaxing muscles and widening the airways of the lungs. Glycopyrrolate reduces secretions in the airways. Budesonide is a corticosteroid that acts on nasal lining cells and prevents the release of certain chemicals that cause inflammatory reactions. Thus, it provides relief from COPD.

Discontinue the medicine and inform your doctor if you observe any allergic reactions or are known to be allergic to any ingredients. This medicine is contraindicated for use in asthma patients, acute episodes of COPD, and the use of other LABA drugs, as it can cause serious side effects. Glycohale FB Inhaler 120 MDI may cause glaucoma, oropharyngeal candidiasis, adrenal suppression, cardiovascular effects, paradoxical bronchospasm, serious anaphylactic reactions, hypokalaemia, hyperglycaemia, pneumonia and deterioration of disease. Therefore, inform your doctor if you have any conditions like liver/kidney disease, glaucoma, asthma, heart disease, seizures, weak immune system, osteoporosis, diabetes, thyroid disorders, prostate/bladder problems, a serious infection, or medication history of anticholinergics, atropine, other LABA drugs, antifungal or anti-HIV medicines if you are pregnant or breastfeeding, please inform your doctor before using Glycohale FB Inhaler 120 MDI. Glycohale FB Inhaler 120 MDI is not recommended for children as the safety is not established. This medicine may cause harm to the developing baby. Hence, it is advised to inform your doctor if you are pregnant or breastfeeding before starting the treatment.